Hepatotoxicity induced by coxibs: how concerned should we be?-Reference-Cited by-同舟云学术

Hepatotoxicity induced by coxibs: how concerned should we be?

Published:2016-08-26 Issue:11 Volume:15 Page:1463-1475
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Bessone Fernando¹,Hernandez Nelia²,Roma Marcelo Gabriel³,Ridruejo Ezequiel⁴,Mendizabal Manuel⁵,Medina-Cáliz Inmaculada⁶,Robles-Díaz Mercedes⁶,Lucena M. Isabel⁶,Andrade Raúl J.⁶

Affiliation:

1. Hospital Provincial del Centenario, University of Rosario School of Medicine, Gastroenterology & Hepatology Department, Rosario, Argentina

2. Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay

3. Instituto de Fisiología Experimental (CONICET-UNR), Facultad de Ciencias Bioquímicas y Farmaceúticas, Universidad de Rosario, Rosario, Argentina

4. Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno ‘CEMIC’, Medicine Department, Hepatology Section, Ciudad Autónoma de Buenos Aires, Argentina

5. Hospital Universitario Austral, Herpatology & Liver Transplant Unit, Buenos Aires, Argentina

6. UGC de Ap Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd, Málaga, Spain

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2016.1225719

Reference84 articles.

1. Anti-Inflammatory Drugs in the 21st Century

2. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis

3. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis

4. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis

5. Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current challenges for therapy of comorbid patients: a new look at celecoxib. A review;Terapevticheskii arkhiv;2024-06-03

2. Research progress on rat model of drug-induced liver injury established by nonsteroidal anti-inflammatory drug (celecoxib) and royal jelly ameliorative effect;Journal of Complementary and Integrative Medicine;2024-01-29

3. Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management;Biochemical Pharmacology;2023-10

4. Detection and identification of imperatorin metabolites in rat, dog, monkey, and human liver microsomes by ultra‐high‐performance liquid chromatography combined with high‐resolution mass spectrometry and Compound Discoverer software;Biomedical Chromatography;2023-07-16

5. Selective COX-2 Inhibitor Etoricoxib’s Liposomal Formulation Attenuates M2 Polarization of TAMs and Enhances its Anti-metastatic Potential;Pharmaceutical Research;2023-01-20